We're opening this space to share the kind of material we wish existed when we started sourcing research peptides ourselves: careful, source-cited explainers on GLP-1 pharmacology, notes on what changes when a new clinical readout drops, and the occasional behind-the-scenes look at how we vet manufacturers and run third-party purity testing.
Everything here is written for an audience working in a research context: biochemists, lab managers, and independent investigators evaluating compounds like retatrutide, tirzepatide, and semaglutide. We will not give dosing advice or make therapeutic claims. The peptides we ship are for research use only and are not intended for human consumption.
Expect short news posts when something material shifts in the field, and longer educational posts when a topic deserves a proper walkthrough. If there's something you'd like us to cover, the contact form is the fastest way to reach us.